블로그
-
Advances in the mechanism of CDK4/6 inhibitor resistance in HR+/HER2− breast cancer
, breast cancer is the most prevalent form of a malignant tumour. This is a specific treatment that stops the growth of cancer cells.......
blog.naver.com · 2025.11.02
-
Dual targeting CDK4/6 and CDK7 augments tumor response and anti-tumor immunity in breast cancer...
Dual targeting CDK4/6 and CDK7 augments tumor response and anti-tumor immunity in breast cancer models Kinetic analyses reveal that CDK7 inhibitors.......
blog.naver.com · 2025.08.15
-
Sensitivity Measures in Studies of Cancer Early Detection Biomarkers
Sensitivity Measures in Studies of Cancer Early Detection Biomarkers Background: The sensitivity of a cancer screening biomarker to detect prevalent preclinical cancer drives screening benefit.
blog.naver.com · 2025.07.01
-
Density of T-cell Subsets in Colorectal Cancer in Relation to Disease-Specific Survival
Density of T-cell Subsets in Colorectal Cancer in Relation to Disease-Specific Survival Background: Prior with colorectal cancer survival; however, few studies have considered the potentially distinct roles
blog.naver.com · 2025.06.30
-
Novel Metastasis Suppressor PI3KC2β Is Mediated by mTORC1 Signaling in Breast Cancer
or mutation accounts for 25% of patients with breast cancer that can advance to metastatic disease. Therefore, it is important to identify novel genes that mediate metastasis in HER2+ breast cancer.
blog.naver.com · 2025.06.05
-
ASSOCIATION BETWEEN PRIVATE WELL WATER EXPOSURE AND PROSTATE CANCER SEVERITY
ASSOCIATION BETWEEN PRIVATE WELL WATER EXPOSURE AND PROSTATE CANCER SEVERITY: ANALYSIS OF A NATIONAL Limited evidence exists for environmental pollutants that may increase risks of prostate cancer, which
blog.naver.com · 2025.06.13
-
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or ...
Study of Fulvestrant plus Abemaciclib in Hormone Receptor–Positive Advanced or Recurrent Endometrial Cancer alterations that promote estrogen receptor–independent cyclin D1–CDK4/6 activation.
blog.naver.com · 2025.06.04
-
[PLOS ONE 게재] Exploring the experiences of cancer patients: What drives them to seek treatment out..
Exploring the experiences of cancer patients: What drives them to seek treatment outside their residential area and what are the experiences resulting from that decision?
blog.naver.com · 2025.02.07
-
알테오젠, Merck UBS Global Healthcare Conference (Transcript)
키트루다의 성장과 더불어 폐암에서의 진단 확대와 관련된 코멘트. it's a setting, especially in lung cancer, where we continue to look at how do we just expand diagnosis, right, to make sure that patients are actually diagnosed as early
blog.naver.com · 2024.11.13
-
2023/05/03 영어공부 2일차(I'm sorry for your loss. 외)
She died of cancer. I'm sorry. Give my regards to your family. I'll do that. Thanks again, 단어/숙어 1.
blog.naver.com · 2023.05.03
